|Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndrome.|
|PMID: 23371956 Owner: NLM Status: MEDLINE|
|BACKGROUND AND OBJECTIVES: X-linked Alport syndrome (X-AS) is caused by mutations of the COL4A5 gene, which encodes for the collagen IV α5 chain (α5[COLIV]), resulting in structural and functional abnormalities of the glomerular basement membrane (GBM) and leading to CKD. The aim of the present study was to evaluate the prognostic value of residual collagen IV chain expression in the GBM of patients with X-AS.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The medical records of 22 patients with X-AS from 21 unrelated families collected between 1987 and 2009 were reviewed (median age at last follow-up, 19.9 years; range, 5.4-35.1 years); GBM expression of α1, α3, and α5(COLIV) chains was assessed by immunofluorescence microscopy.
RESULTS: GBM distribution of the α5(COLIV) chain was diffuse in 1 and segmental or absent in 21 of the 22 patients; the expression of the α3(COLIV) chain was diffuse in 5 of 22 patients and segmental or absent in 17 of 22 patients. Patients with diffuse staining for the α3(COLIV) chain presented with proteinuria significantly later (median age, 16.9 versus 6.1 years; P=0.02) and reached an estimated GFR < 90 ml/min per 1.73 m(2) at an older age (median age, 27.0 versus 14.9 years; P=0.01) compared with patients with segmental or absent staining. Two thirds of patients with abnormal α3(COLIV) expression by immunofluorescence studies had null or truncating COL4A5 mutations, as opposed to none of the 4 tested patients with diffuse α3(COLIV) chain glomerular distribution.
CONCLUSIONS: These results indicate that maintained expression of the α3(COLIV) chain is an early positive prognostic marker in patients with X-linked Alport symdrome.
|Laura Massella; Concetta Gangemi; Kostas Giannakakis; Antonella Crisafi; Tullio Faraggiana; Chiara Fallerini; Alessandra Renieri; Andrea Onetti Muda; Francesco Emma|
Related Documents :
|8227836 - Changes in left and right atrial size after cardioversion of atrial fibrillation: role ...
20233976 - Cognitive function and anticoagulation control in patients with atrial fibrillation.
1879156 - A study of plane bisection in four cases of visual neglect.
18771546 - Identification of unusual conditions after atrial septal defect repair by systematic tr...
21056136 - Perioperative atrial arrhythmias in noncardiothoracic patients: a review of risk factor...
19935106 - Spleen artery embolization aggravates endotoxin hyporesponse of peripheral blood mononu...
|Type: Journal Article Date: 2013-01-31|
|Title: Clinical journal of the American Society of Nephrology : CJASN Volume: 8 ISSN: 1555-905X ISO Abbreviation: Clin J Am Soc Nephrol Publication Date: 2013 May|
|Created Date: 2013-05-08 Completed Date: 2013-12-16 Revised Date: 2014-05-07|
Medline Journal Info:
|Nlm Unique ID: 101271570 Medline TA: Clin J Am Soc Nephrol Country: United States|
|Languages: eng Pagination: 749-55 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Autoantigens / analysis*
Biological Markers / analysis
Collagen Type IV / analysis*
Fluorescent Antibody Technique*
Glomerular Basement Membrane / chemistry*, pathology, physiopathology
Glomerular Filtration Rate
Nephritis, Hereditary / genetics, metabolism*, pathology, physiopathology
Predictive Value of Tests
Proteinuria / genetics, metabolism
|0/Autoantigens; 0/Biological Markers; 0/COL4A1 protein, human; 0/COL4A5 protein, human; 0/Collagen Type IV; 0/type IV collagen alpha3 chain|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cumulative patency of contemporary fistulas versus grafts (2000-2010).
Next Document: Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients.